NCT03760575 2025-12-04Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)Abramson Cancer Center at Penn MedicinePhase 1 Recruiting20 enrolled